MEASURING SIDE EFFECTS OF PSYCHOPHARMACOLOGIC MEDICATION IN INDIVIDUALS WITH MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES
Gardado en:
KALACHNIK, J.E., MEASURING SIDE EFFECTS OF PSYCHOPHARMACOLOGIC MEDICATION IN INDIVIDUALS WITH MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, Vol. 5, no. 4 (1999), p. 348-359.
Ref.
83249
Localización:
SIIS R.1376
Palabras clave:
Discapacidad intelectual, Efectos no deseados, Fármacos, Tratamiento
Discapacidad intelectual, Efectos no deseados, Fármacos, Tratamiento
Títulos similares: MEASURING SIDE EFFECTS OF PSYCHOPHARMACOLOGIC MEDICATION IN INDIVIDUALS WITH MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES
- BRIEF REPORT: CLONAZEPAM BEHAVIORAL SIDE EFFECTS WITH AN INDIVIDUAL WITH MENTAL RETARDATION
- BENZODIAZEPINE BEHAVIORAL SIDE EFFECTS: REVIEW AND IMPLICATIONS FOR INDIVIDUALS WITH MENTAL RETARDATION
- ANTIEPILEPTIC DRUG BEHAVIORAL SIDE EFFECTS IN INDIVIDUALS WITH MENTAL RETARDATION AND THE USE OF BEHAVIORAL MEASUREMENT TECHNIQUES
- AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
- PSYCHOPHARMACOLOGY. EN: MANUAL OF DIAGNOSIS AND PROFESSIONAL PRACTICE IN MENTAL RETARDATION
- PSYCHOPHARMACOLOGY OF MOOD DISORDER IN PERSONS WITH MENTAL RETARDATION AND AUTISM